Shock wave therapy is a non-invasive treatment used in wide areas of medical field, such as urology, cardiology, orthopedics, and physical therapy, among others. It is an alternative for orthopedic ...
The FDA has approved the sale of the Dermapace System, the first shock wave device intended to treat diabetic foot ulcers. The FDA has approved the sale of the Dermapace System, the first shock wave ...
With the number of bogus remedies and treatments floating around, claiming to provide relief for various ailments, the FDA really has its work cut out for it. I mean, can you imagine trying to wade ...
With the number of bogus remedies and treatments floating around, claiming to provide relief for various ailments, the FDA really has its work cut out for it. I mean, can you imagine trying to wade ...
ShockWave’s disruptive approach within the calcified cardiovascular disease space creates a first-mover advantage offering the opportunity of robust sales growth. ShockWave Medical’s business model ...
SANTA CLARA, Calif., Sept. 03, 2019 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc., a pioneer in the development and commercialization of Intravascular Lithotripsy (IVL) to treat complex calcified ...
The FDA on Dec. 28 permitted the marketing of Sanuwave’s Dermapace System to treat adults with diabetic foot ulcers. Here are three things to know. 1. The Dermapace System is an external shock wave ...
Federal health regulators have green-lighted the use of the first shock wave device that promotes healing of foot ulcers in patients with diabetes. In a news release published Dec. 28, the U.S. Food ...
As an adjunct to bypass surgery for ischemic cardiomyopathy, a cardiac shockwave therapy aimed at regenerating ischemic myocardium boosted left ventricular ejection fraction (LVEF) and physical ...
Today, the U.S. Food and Drug Administration permitted the marketing of the Dermapace System, the first shock wave device intended to treat diabetic foot ulcers. "Diabetes is the leading cause of ...
FDA approves shockwave therapy for diabetic foot ulcers. The FDA has approved the Dermapace System for treatment of chronic, full-thickness diabetic foot ulcers. The US Food & Drug Administration (FDA ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results